These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 34209277)

  • 1. A Gut-Ex-Vivo System to Study Gut Inflammation Associated to Inflammatory Bowel Disease (IBD).
    Gagliardi M; Monzani R; Clemente N; Fusaro L; Saverio V; Grieco G; Pańczyszyn E; Yissachar N; Boccafoschi F; Corazzari M
    Biology (Basel); 2021 Jun; 10(7):. PubMed ID: 34209277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Gut-Ex-Vivo System (GEVS) Is a Dynamic and Versatile Tool for the Study of DNBS-Induced IBD in BALB/C and C57BL/6 Mice, Highlighting the Protective Role of Probiotics.
    Monzani R; Gagliardi M; Clemente N; Saverio V; Pańczyszyn E; Santoro C; Yissachar N; Visciglia A; Pane M; Amoruso A; Corazzari M
    Biology (Basel); 2022 Oct; 11(11):. PubMed ID: 36358275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut-Ex-Vivo system as a model to study gluten response in celiac disease.
    Gagliardi M; Clemente N; Monzani R; Fusaro L; Ferrari E; Saverio V; Grieco G; Pańczyszyn E; Carton F; Santoro C; Del Mare-Roumani S; Amidror S; Yissachar N; Boccafoschi F; Zucchelli S; Corazzari M
    Cell Death Discov; 2021 Mar; 7(1):45. PubMed ID: 33712560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pro- and anti-inflammatory cytokine gene single-nucleotide polymorphisms in inflammatory bowel disease.
    López-Hernández R; Valdés M; Campillo JA; Martínez-García P; Salama H; Bolarin JM; Martínez H; Moya-Quiles MR; Minguela A; Sánchez-Torres A; Botella C; Salgado G; Miras M; Carballo F; Muro M
    Int J Immunogenet; 2015 Feb; 42(1):38-45. PubMed ID: 25359546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome.
    Khan I; Ullah N; Zha L; Bai Y; Khan A; Zhao T; Che T; Zhang C
    Pathogens; 2019 Aug; 8(3):. PubMed ID: 31412603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2,3,5,4'-Tetrahydroxystilbene-2-O-β-D-glucoside, a major bioactive component from Polygoni multiflori Radix (Heshouwu) suppresses DSS induced acute colitis in BALb/c mice by modulating gut microbiota.
    He X; Liu J; Long G; Xia XH; Liu M
    Biomed Pharmacother; 2021 May; 137():111420. PubMed ID: 33761623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. News from the "5th International Meeting on Inflammatory Bowel Diseases" CAPRI 2010.
    Latella G; Fiocchi C; Caprili R
    J Crohns Colitis; 2010 Dec; 4(6):690-702. PubMed ID: 21122584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA 301A Promotes Intestinal Inflammation and Colitis-Associated Cancer Development by Inhibiting BTG1.
    He C; Yu T; Shi Y; Ma C; Yang W; Fang L; Sun M; Wu W; Xiao F; Guo F; Chen M; Yang H; Qian J; Cong Y; Liu Z
    Gastroenterology; 2017 May; 152(6):1434-1448.e15. PubMed ID: 28193514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic interleukin-9 in inflammatory bowel disease: Association with mucosal healing in ulcerative colitis.
    Matusiewicz M; Neubauer K; Bednarz-Misa I; Gorska S; Krzystek-Korpacka M
    World J Gastroenterol; 2017 Jun; 23(22):4039-4046. PubMed ID: 28652656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional Characterization of Inflammatory Bowel Disease-Associated Gut Dysbiosis in Gnotobiotic Mice.
    Nagao-Kitamoto H; Shreiner AB; Gillilland MG; Kitamoto S; Ishii C; Hirayama A; Kuffa P; El-Zaatari M; Grasberger H; Seekatz AM; Higgins PD; Young VB; Fukuda S; Kao JY; Kamada N
    Cell Mol Gastroenterol Hepatol; 2016 Jul; 2(4):468-481. PubMed ID: 27795980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A galectin-specific signature in the gut delineates Crohn's disease and ulcerative colitis from other human inflammatory intestinal disorders.
    Papa Gobbi R; De Francesco N; Bondar C; Muglia C; Chirdo F; Rumbo M; Rocca A; Toscano MA; Sambuelli A; Rabinovich GA; Docena GH
    Biofactors; 2016; 42(1):93-105. PubMed ID: 26891020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into the interplay between autophagy, gut microbiota and inflammatory responses in IBD.
    Larabi A; Barnich N; Nguyen HTT
    Autophagy; 2020 Jan; 16(1):38-51. PubMed ID: 31286804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphologic criteria applicable to biopsy specimens for effective distinction of inflammatory bowel disease from other forms of colitis and of Crohn's disease from ulcerative colitis.
    Tanaka M; Riddell RH; Saito H; Soma Y; Hidaka H; Kudo H
    Scand J Gastroenterol; 1999 Jan; 34(1):55-67. PubMed ID: 10048734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic Factors Interact With Tobacco Smoke to Modify Risk for Inflammatory Bowel Disease in Humans and Mice.
    Yadav P; Ellinghaus D; Rémy G; Freitag-Wolf S; Cesaro A; Degenhardt F; Boucher G; Delacre M; ; Peyrin-Biroulet L; Pichavant M; Rioux JD; Gosset P; Franke A; Schumm LP; Krawczak M; Chamaillard M; Dempfle A; Andersen V
    Gastroenterology; 2017 Aug; 153(2):550-565. PubMed ID: 28506689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current concepts in pediatric inflammatory bowel disease; IL10/IL10R colitis as a model disease.
    Almana Y; Mohammed R
    Int J Pediatr Adolesc Med; 2019 Mar; 6(1):1-5. PubMed ID: 31304220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation.
    Vivinus-Nébot M; Frin-Mathy G; Bzioueche H; Dainese R; Bernard G; Anty R; Filippi J; Saint-Paul MC; Tulic MK; Verhasselt V; Hébuterne X; Piche T
    Gut; 2014 May; 63(5):744-52. PubMed ID: 23878165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-7 receptor influences anti-TNF responsiveness and T cell gut homing in inflammatory bowel disease.
    Belarif L; Danger R; Kermarrec L; Nerrière-Daguin V; Pengam S; Durand T; Mary C; Kerdreux E; Gauttier V; Kucik A; Thepenier V; Martin JC; Chang C; Rahman A; Guen NS; Braudeau C; Abidi A; David G; Malard F; Takoudju C; Martinet B; Gérard N; Neveu I; Neunlist M; Coron E; MacDonald TT; Desreumaux P; Mai HL; Le Bas-Bernardet S; Mosnier JF; Merad M; Josien R; Brouard S; Soulillou JP; Blancho G; Bourreille A; Naveilhan P; Vanhove B; Poirier N
    J Clin Invest; 2019 Apr; 129(5):1910-1925. PubMed ID: 30939120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA signatures differentiate Crohn's disease from ulcerative colitis.
    Schaefer JS; Attumi T; Opekun AR; Abraham B; Hou J; Shelby H; Graham DY; Streckfus C; Klein JR
    BMC Immunol; 2015 Feb; 16():5. PubMed ID: 25886994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.